Snapback Stack Vial (Proprietary Blend 10mg + TB500 10mg)

• May accelerate healing of muscles, tendons, ligaments, and wounds
• May reduce inflammation and support joint repair
• May promote gut lining health and recovery after surgery
• May enhance overall tissue regeneration and resilience

• Dose: 500mcg of each per dose
  • Draw 20 units (0.2mL) for a dose of 500mcg
  • 5 days per week, 2 consecutive days off

• Duration: 2 months, cycle 1 week of between months 
• Reconstitute: Add 4mL of bacteriostatic water to 10mg vial
• Subcutaneous Injection

BPC-157:

• Angiogenesis and Vascular Repair:
  • BPC-157 promotes angiogenesis by upregulating vascular endothelial growth factor (VEGF) and related pro-angiogenic mediators. This enhances neovascularization, improves tissue oxygenation, and accelerates perfusion in areas of injury.
• Nitric Oxide (NO) Modulation:
  • By regulating nitric oxide signaling, BPC-157 supports endothelial integrity and vasodilation. This modulation helps maintain healthy blood flow, reduces oxidative stress, and stabilizes vascular function during tissue repair.
• Collagen Synthesis and Extracellular Matrix Remodeling:
  • BPC-157 stimulates fibroblast activity, leading to increased collagen deposition and extracellular matrix (ECM) organization. This structural support strengthens connective tissues and accelerates wound healing in tendons, ligaments, and muscles.
• Inflammatory Regulation:
  • The peptide modulates key genes involved in inflammatory signaling, reducing pro-inflammatory cytokine activity while enhancing anti-inflammatory mediators. This balance minimizes tissue irritation and promotes a regenerative microenvironment.
• Cytoprotective and Regenerative Actions:
  • BPC-157 exerts potent cytoprotective effects on both epithelial and endothelial cells. It stabilizes cell membranes, enhances mitochondrial function, and protects against oxidative or chemical injury to maintain cellular homeostasis.
• Tissue Regeneration and Healing:
  • Through coordinated modulation of angiogenic, inflammatory, and regenerative pathways, BPC-157 accelerates overall tissue repair. These actions collectively improve recovery from musculoskeletal injuries, gastrointestinal damage, and systemic inflammatory stress.

TB-500: 

• Cellular Migration and Tissue Repair:
  •  TB-500 accelerates tissue regeneration by promoting cell migration to areas of injury. It activates components of the extracellular matrix (ECM), enhancing cell adhesion and motility essential for wound healing and structural repair.
• Collagen Synthesis:
  •  TB-500 supports the synthesis of collagen, a key structural protein critical for the repair of skin, muscle, tendon, and joint tissue. Increased collagen production strengthens connective tissue integrity and accelerates recovery.
• Angiogenesis:
  •  Through stimulation of new blood vessel formation, TB-500 improves local oxygen and nutrient delivery to damaged tissues. This angiogenic activity enhances cellular regeneration and recovery following injury or surgery.
• Anti-Inflammatory Action:
  •  TB-500 exerts potent anti-inflammatory effects by downregulating pro-inflammatory cytokines and modulating the inflammatory response. This reduces tissue swelling, pain, and oxidative stress, promoting faster healing.
• Tissue Regeneration and Muscle Repair:
  • TB-500 enhances muscle cell proliferation and differentiation via upregulation of key growth factors, including vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF). These actions drive muscle regeneration and support recovery from strain or trauma.
• Neuroprotective Effects:
  •  TB-500 demonstrates neuroprotective benefits through its ability to promote neuronal repair and support myelin sheath formation. This contributes to improved nerve function and resilience following injury.
• Immune Modulation:
  •  TB-500 modulates immune function by influencing thymic activity and T-cell response. Enhanced immune regulation supports tissue recovery while helping the body resist infection and chronic inflammation.

• Disclaimer: For Research Purposes Only – All products on this site are for Research and Development use only. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. Celia Health is a supplier of research-use chemicals manufactured in a CGMP facility in the US. Celia Health  is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act.